The COVID-19 pandemic has exposed weaknesses in traditional health care systems, which has led to renewed interest in artificial intelligence (AI), specifically in applied diagnostics.
In particular, this was visible at this year’s J.P. Morgan Health Care Conference where a slew of mega medtech players, including Medtronic plc, Biogen, Inc